Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy / S. Agewall, M. Cattaneo, J.P. Collet, F. Andreotti, G.Y.H. Lip, F.W.A. Verheugt, K. Huber, E.L. Grove, J. Morais, S. Husted, S. Wassmann, G. Rosano, D. Atar, A. Pathak, K. Kjeldsen, R.F. Storey, ESC working group on cardiovascular pharmacology, drug therapy, ESC working group on thrombosis. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 34:23(2013 Jun), pp. 1708-1713. [10.1093/eurheartj/eht042]

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

M. Cattaneo
Secondo
;
G. Rosano;
2013

adenosine; aspirin; benzimidazoles; cardiovascular diseases; drug interactions; drug therapy, combination; fibrinolytic agents; humans; piperazines; platelet aggregation inhibitors; proton pump inhibitors; purinergic P2Y receptor antagonists; thiophenes; ticlopidine; warfarin; beta-alanine; cardiology and cardiovascular medicine
Settore MED/09 - Medicina Interna
giu-2013
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/256615
Citazioni
  • ???jsp.display-item.citation.pmc??? 41
  • Scopus 160
  • ???jsp.display-item.citation.isi??? 128
social impact